CRESTOR Helps Lower Reduced Risk of Cardiovascular Disease

 

September 2, 2009

CRESTOR (rosuvastatin calcium) 20 mg tablets, as an adjunct to diet in adult patients, helps lowered LDL-C, and raise HDL-C to help slow the progression of atherosclerosis.

CRESTOR has now received regulatory approval in over 95 countries. Nearly 17 million patients have been prescribed CRESTOR worldwide. Data from clinical trials and real world use shows that the safety profile for CRESTOR is in line with other marketed statins.

For more information: www.astrazeneca-us.com